1. Progress in improving the pathogen safety of red cell concentrates;Chapman;Vox Sang,2000
2. Production of pathogen-inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical study;AuBuchon;Transfusion,2002
3. Pathogen inactivated red blood cells using INACTINE™ technology demonstrate 24 hour post transfusion recovery equal to untreated red cells after 42 days of storage;Snyder;Blood,2001
4. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine;Bahnemann;Vaccine,1990
5. Principles of selective inactivation of the viral genome: dependence of the rate of viral RNA modification on the number of protonizable groups in ethylenimine oligomers;Budowsky;Vaccine Res,1996